This section contains information and documents on SCHOTT Pharma’s Annual General Meetings.
This section contains information and documents on SCHOTT Pharma’s Annual General Meetings.
SCHOTT Pharma – Annual General Meeting 2025
The Annual General Meeting of SCHOTT Pharma AG & Co. KGaA took place on Tuesday, 4 February 2025 as a virtual Annual General Meeting.
All members of the Management Board of SCHOTT Pharma Management AG, being the General Partner of SCHOTT Pharma AG & Co. KGaA, and of the Supervisory Board of SCHOTT Pharma AG & Co. KGaA participated during the whole General Meeting.
Invitation to the Annual Shareholders’ Meeting and Forms
Invitation to the Annual Shareholders’ Meeting 2025
PDFProxy form (German only)
PDFDocuments related to the agenda items
Financial Statements of SCHOTT Pharma AG & Co. KGaA for the fiscal year 2023/2024
PDFProposal of the personally liable partner on the appropriation of the net retained profit
PDFRemuneration Report
PDFCV Prof. Dr. Wolfram Carius
PDFProfit Transfer Agreement SCHOTT Pharma Mexico GmbH (German only)
PDFReport on the Profit Transfer Agreement (German only)
PDFFinancial Statement of SCHOTT Pharma Mexico GmbH for the fiscal year 2023/2024 (German only)
PDFFinancial Statement of SCHOTT Pharma Mexico GmbH for the fiscal year 2022/2023 (German only)
PDFFinancial Statement of SCHOTT Pharma Mexico GmbH for the fiscal year 2021/2022 (German only)
PDFConsolidated Financial Statements 2023/2024 (extract from the annual areport 2023/2024)
PDFConsolidated Financial Statements 2022/2023 (extract from the annual areport 2022/2023)
PDFFinancial Statements of SCHOTT Pharma AG & Co. KGaA for the fiscal year 2022/2023
PDFFinancial Statement of SCHOTT Pharma AG & Co. KGaA for the fiscal year 2021/2022 (German only)
PDFSpeech and Results
Speech (German)
PDFPresentation (German)
PDFVoting Results (German)
PDFAnnouncement of dividend and appropriation of profits
PDFInformation according to Table 8 of the Annex of the Implementing Regulation (EU) 2018/1212
PDFOther documents
Explanations on the rights of the shareholders
PDFInformation pursuant to Commission Implementing Regulation (EU) 2018/1212 for notifications pursuant to Section 125 of the German Stock Corporation Act (AktG)
PDFInformation on data protection
Information on Data Protection
PDFArticles of Association of SCHOTT Pharma AG & Co. KGaA
Articles of Association of SCHOTT Pharma AG & Co. KGaA (German only)
PDFSCHOTT Pharma – Annual General Meeting 2024
The Annual General Meeting of SCHOTT Pharma AG & Co. KGaA took place on Thursday, 14 March 2024 as a virtual Annual General Meeting. Below you will find information on our first Annual General Meeting 2024.
Invitation to the Annual Shareholders’ Meeting and Forms
Invitation to the Annual Shareholders’ Meeting 2024
PDFProxy form (German only)
PDFDocuments related to the agenda items
Financial statements of SCHOTT Pharma AG & Co. KGaA for the fiscal year 2022/2023
PDFProposal of the personally liable partner on the appropriation of the net retained profit
PDFRemuneration Report
PDFRemuneration System for the Members of the Management Board of the personally liable partner
PDFRemuneration System for the Members of the Supervisory Board
PDFSpeech and Results
Speech (German)
PDFPresentation (German)
PDFVoting Results (German)
PDFAnnouncement of dividend and appropriation of profits
PDFInformation according to Table 8 of the Annex of the Implementing Regulation (EU) 2018/1212
PDFOther documents
Explanations on the rights of the shareholders
PDFTotal number of shares and voting rights at the time of convocation
PDFInformation pursuant to Commission Implementing Regulation (EU) 2018/1212 for notifications pursuant to Section 125 of the German Stock Corporation Act (AktG)
PDFInformation on data protection
Information on Data Protection
PDFArticles of Association of SCHOTT Pharma AG & Co. KGaA
Articles of Association of SCHOTT Pharma AG & Co. KGaA (German only)
PDF